Finance

Lists
Why is BOT down 5,00%?
Dive Deeper
BOT:ASX
Botanix Pharmaceuticals Ltd
0,0095 AUD
-5,00%
(-0,00050) 1D
13 ნოე, 15:04:35 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for BOT...
Open
0,01 AUD
High
0,01 AUD
Low
0,01 AUD
Mkt. cap
23,62 მლნ.
Avg. vol.
10,14 მლნ.
Volume
658,77 ათ.
52-wk high
0,15 AUD
52-wk low
0,01 AUD
EPS
-0,03 AUD
Shares outstanding
2,76 მლრდ.
No. of employees
11
Open
0,01 AUD
High
0,01 AUD
Low
0,01 AUD
Mkt. cap
23,62 მლნ.
Avg. vol.
10,14 მლნ.
Volume
658,77 ათ.
52-wk high
0,15 AUD
52-wk low
0,01 AUD
EPS
-0,03 AUD
Shares outstanding
2,76 მლრდ.
No. of employees
11
News stories
From web sources and news partners
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
27 ივლ. 2026
Fiscal period
Q4 2026
- / -
Revenue / Est. (AUD)
8,65 მლნ. / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
8,25 მლნ.
8,25 მლნ.
8,65 მლნ.
8,65 მლნ.
Cost of goods sold
2,98 მლნ.
2,98 მლნ.
4,19 მლნ.
4,19 მლნ.
Cost of revenue
2,98 მლნ.
2,98 მლნ.
4,19 მლნ.
4,19 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,32 მლნ.
18,32 მლნ.
19,70 მლნ.
19,70 მლნ.
Operating expense
22,08 მლნ.
22,08 მლნ.
22,30 მლნ.
22,30 მლნ.
Total operating expenses
25,06 მლნ.
25,06 მლნ.
26,49 მლნ.
26,49 მლნ.
Operating income
-16,81 მლნ.
-16,81 მლნ.
-17,85 მლნ.
-17,85 მლნ.
Other non operating income
683,30 ათ.
683,30 ათ.
109,28 ათ.
109,28 ათ.
EBT including unusual items
-16,60 მლნ.
-16,60 მლნ.
-18,29 მლნ.
-18,29 მლნ.
EBT excluding unusual items
-16,60 მლნ.
-16,60 მლნ.
-18,29 მლნ.
-18,29 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16,60 მლნ.
-16,60 მლნ.
-18,29 მლნ.
-18,29 მლნ.
Net profit margin
-201,11%
-201,11%
-211,46%
-211,46%
Earnings per share
-
-
-
-
Interest and investment income
352,66 ათ.
352,66 ათ.
202,18 ათ.
202,18 ათ.
Interest expense
-802,39 ათ.
-802,39 ათ.
-616,20 ათ.
-616,20 ათ.
Net interest expenses
-449,74 ათ.
-449,74 ათ.
-414,02 ათ.
-414,02 ათ.
Depreciation and amortization charges
593,18 ათ.
593,18 ათ.
565,11 ათ.
565,11 ათ.
EBITDA
-16,22 მლნ.
-16,22 მლნ.
-17,28 მლნ.
-17,28 მლნ.
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google აპები